# HALOZYME THERAPEUTICS, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/halozyme-therapeutics-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 16 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-05T15:31:01.100054+00:00 | | Last reviewed | 2026-10-05T15:31:01.100054+00:00 | ## Identity - Legal name: HALOZYME THERAPEUTICS, INC. - Display name: HALOZYME THERAPEUTICS, INC. ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}` - Claim alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:bernadette-connaughton","name":"Bernadette Connaughton"},"source_id":"board_seats"}` - Claim alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:matthew-l-posard","name":"Matthew L. Posard"},"source_id":"board_seats"}` ## Leadership - Bernadette Connaughton: Director, Compensation · Chair. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:6. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b. - Matthew L. Posard: Director, Audit; Nominating and Governance · Chair. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:7. Valid from: 2013-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b. - Cortney Caudill: Senior Vice President, Chief Operating Officer. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:8. Valid from: 2026-02-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c896607eb5fa02c7a3f3bcf4e4b8769d2792afd74909ef668516e6ace0a89d05. - Helen I. Torley: President, Chief Executive Officer and Director. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:9. Valid from: 2026-02-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:06067af1a397d3909dfbe8c738cf81b9a3b580df32a47918d83b4fcdca72df94. - Mark Snyder: Senior Vice President, General Counsel, Chief Compliance Officer and Secretary. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:10. Valid from: 2026-02-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f3969038db0832d1beab031ff33d2ba5700ff90b9a1781c1333ff4f0ddce1baf. - Nicole LaBrosse: Senior Vice President, Chief Financial Officer. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:leadership_role:11. Valid from: 2026-02-17. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:073f0dc17160a9028a5b6e15f06cab340a281b4dfa440621ab690721961a30e3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair not stated; Members Matthew L. Posard. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. - Compensation: Chair Bernadette Connaughton; Members Bernadette Connaughton (Chair). Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. - Nominating and Governance: Chair Matthew L. Posard; Members Matthew L. Posard (Chair). Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - HALOZYME THERAPEUTICS, INC.. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b. ## Entity Status - Public listing published. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b. ## Published Fact - US. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b. - Healthcare. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b. ## Committee Appointment - Matthew L. Posard: member, Audit. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. - Bernadette Connaughton: chair, Compensation. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. - Matthew L. Posard: chair, Nominating and Governance. Claim: alpha:claim:company:4fda0898-d5bd-4190-bbb1-bc7c1c6f3eda:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:d4442448325901236430ecaf8c5aeac2ac56e0aa4f03fa3dec99d1138294d02b: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/halozyme-therapeutics-inc). - alpha:projection-evidence:document:b3907285327866f69778f0d2143387e5f1c0a0e62778684cbb341ceac3f1ce6b: [Halozyme Therapeutics DEF 14A 2026-03-23](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm). - alpha:projection-evidence:document:c896607eb5fa02c7a3f3bcf4e4b8769d2792afd74909ef668516e6ace0a89d05: [HALO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm). - alpha:projection-evidence:document:06067af1a397d3909dfbe8c738cf81b9a3b580df32a47918d83b4fcdca72df94: [HALO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm). - alpha:projection-evidence:document:f3969038db0832d1beab031ff33d2ba5700ff90b9a1781c1333ff4f0ddce1baf: [HALO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm). - alpha:projection-evidence:document:073f0dc17160a9028a5b6e15f06cab340a281b4dfa440621ab690721961a30e3: [HALO 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm). - alpha:projection-evidence:8fedc405ce4f9cf91d5166ce8933cd771da8d506872d20a59dfaf83b258e3242: [Audit](https://www.sec.gov/Archives/edgar/data/1159036/000115903626000041/halo-20260323.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/halozyme-therapeutics-inc) - [Public Markdown](https://registry.alpha.ac/companies/halozyme-therapeutics-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/halozyme-therapeutics-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/halozyme-therapeutics-inc?format=jsonld) - MCP resource: `alpha://companies/halozyme-therapeutics-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.